Breast Lesion Localization Methods – Advancements in Screening Techniques Favoring Demand for Non-palpable Invasive Surgeries
Breast cancer is a condition characterized by an uncontrolled multiplication of breast cells that form a lump, which may be malignant or non-malignant in nature. Such cells usually form tumors that can often be observed on an x-ray or felt as a lump. Breast cancer occurs most commonly among women aged 40 years and above along with a small percentage of men affected by the same. A novel technique of radio occult lesion localization is currently used for detection of non-palpable suspicious breast lesion, which is one of the latest techniques that is expected to gain major traction and in turn fuel growth of the global breast lesion localization methods market over the forecast period (2016–2024). Breast screening programs are favoring early detection of breast cancer, which is further supporting their appropriate treatment with novel techniques. According to Department of Oncology, part of Oxford University, in 2007, around 25% of the cancers were non-palpable that needed specific treatment such as radio-guided occult lesion localization.
Favorable reimbursement policies favoring growth of the breast lesion localization methods market in developed regions
Favorable reimbursement scenario in several developed countries, especially North America further favors growth in research related to finding novel technique to detect cancer. According to American Cancer Society, one time screening mammogram every 12 months is covered fully under Medicare for all women aged 40 and older. Also, it pays for clinical breast exam (CBE) in every 24 months once, for women with average risk of breast cancer. This in turn is expected to increase in rate of breast cancer screening with subsequent increase in growth for breast lesion localization methods market in the near future.
Mammography is one of the most widely used screening technology to identify breast lumps and particularly breast cancer among middle aged women (44 to 65 years age group).
The global breast lesion localization methods market was valued at US$ 400.9 million in 2015 and is expected to witness a robust CAGR of 11.0% during the forecast period (2016 – 2024).
Figure 1. Global Breast Lesion Localization Methods Market Size and Forecast, US$ Million and Y-o-Y Growth (%), 2014–2024
Source: Coherent Market Insights Analysis (2016)
Rising prevalence and increasing awareness about breast cancer is expected to be one of the primary factor for the growth of breast lesion localization methods market over the period
According to W.H.O, in 2012, breast cancer was the second-most prevalent cancer in the world and most frequent cancer among women, with an estimated around 1.7 Mn new cancer cases diagnosed in 2012. It is the most common cancer in women both in developed and emerging regions. Incidence rates are differ according to region, for instance, the incidence rate in Middle Africa 27 per 100,000 and 92 in Northern America. Furthermore, according to W.H.O, in 2012, breast cancer was the fifth prominent cause for mortality from cancer worldwide. In emerging economies, it is the second highest cause of cancer deaths. In developed regions, it led to around 198,000 deaths in 2012, accounting for 15.4% of all deaths related to cancer. This inadvertently is expected to favor growth of the breast lesion localization methods market in the near future. Furthermore, there has been study that a man also has a risk of developing a breast cancer in their whole life time, although the chances of the situation is mere 1 in 1,000, whereas in female it is around one in every eight women is susceptible for the growth of any type lesion. According to Breastcancer.org, in 2017, in the U.S. around 250,000 cases of invasive breast cancer are expected to be diagnosed along with over 60,000 cases of non-invasive breast cancer. This in turn creates a highly conducive environment for global breast lesion localization methods market in the near future.
Large potential in untapped emerging economies is expected to fuel the growth in breast lesion localization methods market
Continuous rise in population in emerging economies such as India and increasing focus towards strengthening of the healthcare infrastructure in the region are expected to provide major growth traction for the breast lesion localization methods market in the near future. Furthermore, according to The Pink Initiative and Breast Cancer Statistics in India, in 2014, a significantly large population of patients below the age of 50 years suffered from breast cancer. The exact statistics represents that around 16% were in the age between 20 and 40 and 28% were in age between 40 and 50. Increasing awareness in such regions with high potential is expected to improve the time to market of highly effective and advanced products. The breast lesion localization methods market is expected to surge on a wave of renewed interest by healthcare providers and governments alike to tackle the menace of breast cancer in the not-so distant future.
Breast lesion localization methods are invasive or non-invasive techniques used to observe if lesions are palpable or non-palpable, as part of diagnosis of breast cancer. There are various types of breast lesion localization methods used globally to detect the abnormalities in terms of a lump or tumor in the breasts. Rampant increase in number of women opting for preventive screening tests for breast cancer creates a highly conducive environment for growth of the breast lesion localization methods market in the foreseeable future. Among various methods under breast lesion localization methods, radio occult localization lesion localization (ROLL) method is one of the fastest growing segments in terms of revenue share, which in turn is expected to underpin growth of the breast lesion localization methods market in the near future. ROLL is a precise method for early detection of breasts lesion, which includes three-dimensional localization of impalpable breast tumor in the body. It provides a unique advantage of high feasibility in connection with sentinel node biopsy in the same setting.
Rapid strides made in technology and keen interest of healthcare providers to integrate cutting-edge solutions backed up by supportive government norms is fueling growth of this highly lucrative market, especially in developed regions. Furthermore, rise in prevalence of breast cancer globally, especially in Asia Pacific countries would inadvertently support market growth in the near future. In order to alleviate this spike in incidence rate of the malady, governments are focusing on strengthening the healthcare infrastructure through supportive regulatory norms and investments. Government and non-government organizations are actively focusing on developing awareness programs regarding breast cancer. Such initiatives are projected to bring about a rapid shift in market dynamics, with Asia Pacific taking on the mantle from North America to emerge as the largest market for breast lesion localization methods. According to The Economist Intelligence Unit Limited, in 2016, China had a comparatively low breast cancer burden by world standards, with 2012 age standardized ratio for incidence and mortality around 22.1 and 5.4 per 100,000 respectively. However, in India breast cancer incidence by global standards in 2012 age standardized ratio was around 25.8 per 100,000. Despite what the statistics tend to suggest, the extent of the disease has surged significantly unlike the steady rise as estimated earlier in 2009.
This report segments the global breast lesion localization methods market on the basis of technique, end user, and geography. On the basis of technique, the market is categorized into wire guided localization, radio guided occult lesion localization, radioactive seed localization, magnetic tracers and ultrasound guided surgery. The wire guided localization method is further divided into core biopsy needles and fine aspiration needles. On the basis of end user, the market is divided into hospitals, ambulatory and surgical centers, diagnostics centers, oncology centers and others. Among all end users, hospitals segment dominated the breast lesion localization methods market, owing to rapid advancements in medical systems.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 90 market data tables and 40 figures on "Breast Lesion Localization Methods Market - Global forecast to 2024”.
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.